Intrinsic Value of S&P & Nasdaq Contact Us

ResMed Inc. RMD NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
78/100
5/7 Pass
SharesGrow Intrinsic Value
$344.37
+49.3%
Analyst Price Target
$295.88
+28.3%

ResMed Inc. (RMD) has 20 known insider and institutional holders on record. The largest holder is PACE GARY W with 100,578 shares. Other notable holders include PENDARVIS DAVID and Sandercock Brett.

Over the last 12 months, insiders have made 72 transactions in RMD stock — 20 buys (valued at $9.01M) and 24 sells (valued at $7.66M). Insider selling has exceeded buying during this period.

RMD Insider Ownership

Top Holder
PACE GARY W
100,578 shares
Buys (12 mo)
20
$9.01M value
Sells (12 mo)
24
$7.66M value
12-Month Transaction Activity
Buy 28%
Sell 33%
Top Insider Holders
# Name Role Shares Owned Last Filed Relative Size
1 Pace Gary W Director 100,578 2017-11-17
100%
2 Pendarvis David Chief Administrative Officer 89,729 2023-06-07
89%
3 Sandercock Brett Chief Financial Officer 83,495 2026-04-03
83%
4 Farrell Peter C Director 60,773 2026-04-02
60%
5 Farrell Michael J. Chairman and CEO 39,930 2026-03-11
40%
6 Leong Justin Chief Product Officer 29,028 2025-11-24
29%
7 Taylor Ronald R Director 24,771 2025-11-24
25%
8 Mchale Richard President, Rc Business 22,982 2020-08-17
23%
9 Sulpizio Richard Director 17,796 2024-11-22
18%
10 Douglas Robert Andrew President and COO 13,849 2023-11-20
14%
11 Wareham John P Director 10,956 2019-11-05
11%
12 Gill Harjit Director 10,940 2025-11-24
11%
13 Drexler Karen Director 10,602 2025-11-24
11%
14 Blaise Lucile President, Sleep & Rc Business 10,305 2023-11-15
10%
15 Rider Michael J Global General Counsel 9,691 2026-02-06
10%
16 Tan Desney Director 6,002 2025-11-24
6%
17 Hernandez John Director 5,118 2025-11-24
5%
18 De Witte Jan Director 4,261 2025-11-26
4%
19 Delorefice Christopher Director 2,423 2025-11-24
2%
20 Burt Carol Director 2,156 2025-11-24
2%
Recent Transactions (last 12 months)
Date Name Role Type Shares Price Value
2026-04-01 Sandercock Brett Chief Financial Officer Informative Sell 1,000 $224.31 $224.31K
2026-04-01 Farrell Peter C Director Informative Sell 2,000 $225.00 $450K
2026-03-09 Farrell Michael J. Chairman and CEO Option Exercise (Sell) 4,991 $146.34 $730.38K
2026-03-04 Farrell Peter C Director Informative Sell 2,000 $260.22 $520.44K
2026-03-02 Sandercock Brett Chief Financial Officer Informative Sell 1,000 $254.30 $254.3K
2026-02-09 Farrell Michael J. Chairman and CEO Option Exercise (Sell) 4,991 $146.34 $730.38K
2026-02-04 Rider Michael J Global General Counsel Informative Sell 50 $260.00 $13K
2026-02-04 Farrell Peter C Director Informative Sell 2,000 $251.31 $502.62K
2026-02-02 Sandercock Brett Chief Financial Officer Informative Sell 1,000 $257.03 $257.03K
2026-01-07 Farrell Peter C Director Informative Sell 2,000 $248.83 $497.66K
2026-01-07 Farrell Michael J. Chairman and CEO Option Exercise (Sell) 4,991 $146.34 $730.38K
2026-01-02 Rider Michael J Global General Counsel Informative Sell 50 $241.75 $12.09K
2026-01-02 Sandercock Brett Chief Financial Officer Informative Sell 1,000 $241.75 $241.75K
2025-12-08 Farrell Michael J. Chairman and CEO Option Exercise (Sell) 4,991 $146.34 $730.38K
2025-12-03 Farrell Peter C Director Informative Sell 2,000 $251.47 $502.94K
2025-12-01 Rider Michael J Global General Counsel Informative Sell 50 $244.16 $12.21K
2025-12-01 Sandercock Brett Chief Financial Officer Informative Sell 1,000 $244.16 $244.16K
2025-11-24 Mowad-nassar Nicole Director RSU Award 1,331 $250.52 $333.44K
2025-11-25 De Witte Jan Director Informative Sell 2,055 $255.00 $524.03K
2025-11-24 Farrell Michael J. Chairman and CEO RSU Award 33,288 $250.52 $8.34M
2025-11-24 Farrell Peter C Director RSU Award 1,331 $250.52 $333.44K
2025-11-20 Mowad-nassar Nicole Director RSU Award 536 - -
2025-11-20 Hernandez John Director RSU Award 1,073 - -
2025-11-20 Tan Desney Director RSU Award 1,073 - -
2025-11-20 Delorefice Christopher Director RSU Award 1,073 - -
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message